Recent Articles

• 
  Investment / AI MedTech

  Reventures' NRP Firms TL Bio, Rainbow Chosen for TIPS

  TL Bio logo (left), Rainbow Company logo. Image provided by Reventures Reventures (CEO Kim Na-kyung) announced that during the operation of the '2025 NRP Enterprise Development Program' organized by the Gyeonggi Content Agency, it made direct investments of KRW 100 million each in two companies (TL

  2025.12.09
• 
  Drug Development

  Celltrion Develops Injection Reducing Time to 5 Minutes

  Celltrion is set to develop the increasingly in-demand 'Subcutaneous Injection (SC)' formulation. The company aims to differentiate itself by applying SC formulation conversion technology to biosimilars currently under development. Celltrion announced on the 8th that it will apply SC conversion tech

  2025.12.09
• 
  Medical / Research

  Shingles Vaccine Lowers Cardiovascular Risk by 26%

  SK Bioscience's developed live shingles vaccine 'Sky Zoster'. It is currently the only live shingles vaccine available in Korea. GSK's 'Shingrix' is also released as a shingles vaccine, but it is a recombinant subunit vaccine. Provided by SK Bioscience Recently, as temperatures have fallen below fre

  2025.12.09
• 
  Startup / Biotech / FDA

  Medirule: Overcoming FDA Hurdles with AI SaaS

  [SeoulTech x IT Donga Joint Planning] Seoul National University of Science and Technology (hereafter referred to as SeoulTech) operates various support programs to assist the growth of startups, including preliminary and early-stage startup packages, maker spaces, and global collaborations. Furtherm

  2025.12.08
• 
  Medical / Digital Healthcare

  Resort People, Korea Univ. Partner on AI Healthcare

  Wellness lifestyle company Resort People (CEO Kim Tae-ho) announced that it has signed a contract for 'AI Digital Healthcare Technology Commercialization' with Korea University's Digital Innovation Research Center (Director Lee Young-hwan) and has begun joint research. The two institutions aim to pi

  2025.12.08
• 
  Global Expansion

  Ex-Samsung CEO Lee Eun-cheon: “We'll Rebuild ViOL as Medical Aesthetic Platform Firm Through R&D, Clinical Strength”

  Lee Eun-cheon, CEO of Viol. Viol Amid a global economic slowdown and intensifying competition in the aesthetic medical market, medical device company Viol is accelerating its leadership change and organizational restructuring. CEO Lee Eun-cheon, who took office at the end of August, has spent 25 yea

  2025.12.08
• 
  Biotech

  Lunit Seeks FDA Approval for Breast Cancer AI

  Medical AI company Lunit announced on the 8th that it has applied for premarket approval (510(k)) from the U.S. Food and Drug Administration (FDA) for its breast cancer risk prediction solution, 'Lunit INSIGHT Risk'.The 510(k) is a representative FDA approval process that demonstrates a new medical

  2025.12.08
• 
  Medical / Research

  MIRACELL Presents Stem Cell Protocol at Conference

  Dr. Ilias Theodoropoulos, a hematologist, presents on the potential to reverse aging of CD34+ stem cells. Provided by Miracell Stem cell specialist company Miracell announced on the 8th that Dr. Ilias Theodoropoulos, a hematologist, presented clinical results of stem cell therapy using the company's

  2025.12.08
• 
  MedTech

  Kolmar Korea Develops Enzyme Stabilization for Advanced Cosmetics

  Korea Kolmar announced on the 8th that it has developed an innovative technology to maximize the stability of enzymes that enhance skin function. This technology addresses the issue of enzymes being highly sensitive to external environmental changes such as temperature and pH, which has posed challe

  2025.12.08
• 
  Medical / Healthcare

  "Stroke Warning? Check Symptoms, Measure Blood Pressure"

  Professor Jeong Geun-hwa from the Department of Neurology at Seoul National University Hospital emphasized that recognizing the warning signs of a stroke and quickly transporting the patient to a hospital is the best way to increase survival rates and eliminate aftereffects. It is important to caref

  2025.12.06